Highlights Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-25 EDT			5-day change	1st Jan Change
52.87 ^USD	-1.91%		+1.79%	-36.68%

06-24	JPMorgan Cuts Price Target on Cytokinetics to $65 From $77, Maintains Overweight Rating	MT
06-17	Cytokinetics Insider Sold Shares Worth $262,750, According to a Recent SEC Filing	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants	06-17	CI
Sector Update: Health Care Stocks Advance Late Afternoon	06-05	MT
Sector Update: Health Care Stocks Rise Wednesday Afternoon	06-05	MT
Sector Update: Health Care	06-05	MT
Cytokinetics Says Third Party Dropped Takeover Bid Despite Negotiations; Shares Rise	06-05	MT
Cytokinetics CEO Says Board Would Have Backed Actionable Buyout	06-05	DJ
Cytokinetics Says Third Party Did Not Move Forward with Acquisition After Talks	06-04	CI
Cytokinetics Closes $500 Million Stock Offering	05-28	MT
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday	05-23	MT
Nvidia Earnings Fuel Investor Optimism, Driving Premarket Gains for US Equity Futures	05-23	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Tech Stocks Rally on NVIDIA Earnings	05-23	MT
Stocks in motion: e.l.f Beauty soars along with Nvidia	05-23
Top Premarket Decliners	05-23	MT
Cytokinetics, Royalty Pharma Unveil up to $575 Million Funding to Advance Research Pipeline	05-22	MT
Cytokinetics Plans $500 Million Common Stock Offering -- Shares Drop After Hours	05-22	MT
Cytokinetics Q1 Net Loss Narrows, Revenue Declines	05-08	MT
Earnings Flash (CYTK) CYTOKINETICS INCORPORATED Posts Q1 Revenue $835,000, vs. Street Est of $0.9M	05-08	MT
Cytokinetics, Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
Cytokinetics, Incorporated Announces Topline Data from Phase 1 Clinical Study of Ck-4021586	05-08	CI
Cytokinetics, Incorporated Announces CEDAR-HCM Is Open to Enrollment	05-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Highlights

Filters